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Cdc14 activates Cdc15 to promote mitotic exit in budding yeast
Sue L. Jaspersen and David O. Morgan
Inactivation of mitotic cyclin-dependent kinases
(Cdks) is required for cells to exit mitosis [1,2]. In the
budding yeast Saccharomyces cerevisiae, Cdk
inactivation is triggered by the phosphatase Cdc14,
which is activated by a complex network of regulatory
proteins that includes the protein kinase Cdc15 [3–6].
Here we show that the ability of Cdc15 to promote
mitotic exit is inhibited by phosphorylation. Cdc15 is
phosphorylated in vivo at multiple Cdk-consensus
sites during most of the cell cycle, but is transiently
dephosphorylated in late mitosis. Although
phosphorylation appears to have no effect on Cdc15
kinase activity, a non-phosphorylatable mutant of
Cdc15 is a more potent stimulator of mitotic exit than
wild-type Cdc15, indicating that phosphorylation
inhibits Cdc15 function in vivo. Interestingly, inhibitory
phosphorylation of Cdc15 is removed by the
phosphatase Cdc14 in vitro, and overproduction of
Cdc14 leads to Cdc15 dephosphorylation in vivo. Thus,
Cdc15 serves both as an activator and substrate of
Cdc14. Although this scheme raises the possibility that
positive feedback promotes Cdc14 activation, we
present evidence that such feedback is not essential
for Cdc14 activation in vivo. Instead, Cdc15
dephosphorylation may promote some additional
function of Cdc15 that is independent of its effects on
Cdc14 activation.
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Results and discussion
To gain insight into the regulation of the mitotic exit
network, we explored the possibility that Cdc15 is regu-
lated by phosphorylation. Immunoblotting of yeast cell
lysates revealed that hemagglutinin-epitope-tagged Cdc15
(Cdc15HA) migrated in at least five electrophoretic mobility
forms, which collapsed into a single form upon treatment of
immunoprecipitates with l -phosphatase (Figure 1a). In
addition, Cdc15 was labeled with 32P when cells were grown
in media containing radioactive phosphate (see Supplemen-
tary material). 
Cdc15 contains seven consensus Cdk phosphorylation
sites (S/T-P-X-K/R or K/R-S/T-P, in the single-letter
amino-acid code where X represents any amino acid).
Mutation of these seven sites to alanine (the Cdc15-7A
mutant) abolished the lower mobility forms of Cdc15HA
on immunoblots (Figure 1a). In addition, 32P-labeling
in vivo indicated that Cdc15 phosphorylation was unde-
tectable in the Cdc15-7A mutant (see Supplementary
material). On the basis of this result and on the heteroge-
neous gel mobility of Cdc15, we conclude that Cdc15 is
phosphorylated in vivo at a large subset of the protein’s
seven Cdk-consensus sites.
Cdc15 was highly phosphorylated in cells arrested in G1,
S phase, or mitosis (Figure 1b), and in cells arrested in
anaphase because of a loss of function in mitotic-exit genes
(Figure 1c). Analysis of cells released synchronously from a
metaphase arrest, however, revealed a highly reproducible,
transient decrease in Cdc15 phosphorylation at approxi-
mately the time that cells were exiting anaphase (30
min; Figure 1d). Because phosphorylation of Cdc15 occurs
on Cdk-consensus sites, we tested whether Cdc28 is the
kinase that phosphorylates Cdc15 in vivo. Consistent with
this possibility, we found that purified Cdc15 was efficiently
phosphorylated in vitro by purified Cdc28–Clb2 complexes
(data not shown). However, Cdc15 phosphorylation was not
significantly reduced in cells arrested in G1 in which Cdc28
activity was very low (Figure 1b) or in cdc28 mutant cells
arrested at the restrictive temperature (see Supplementary
material). In addition, Cdc15 was rapidly rephosphorylated
in cells progressing out of mitosis into the following G1,
despite the absence of Cdc28 activity (Figure 1d). It there-
fore appears that Cdc28 cannot be the sole kinase responsi-
ble for Cdc15 phosphorylation in vivo.
The fact that Cdc15 is constitutively phosphorylated during
most of the cell cycle and only briefly dephosphorylated in
late mitosis might suggest that a phosphatase, rather than a
kinase, is the limiting regulator of Cdc15 phosphorylation.
The phosphatase Cdc14 is an excellent candidate for such a
regulator, as it is transiently activated following anaphase
[5,6] and is known to dephosphorylate other mitotic regula-
tory proteins at Cdk-consensus sites [3,4]. In addition,
Cdc15 is phosphorylated in cells lacking Cdc14 function
(Figure 1c). Treatment of Cdc15 immunoprecipitates with
purified glutathione-S-transferase (GST)-tagged Cdc14
(GST–Cdc14) resulted in Cdc15 dephosphorylation, similar
to that seen when l -phosphatase was added (Figure 2a).
There was no effect when GST or a catalytically inactive
version of Cdc14 (GST–Cdc14 C283S/R289A) was added.
When GST–Cdc14 or l -phosphatase was added to crude
yeast lysates prepared from cells expressing Cdc15HA, only
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Cdc14 was able to abolish the upper mobility forms of
Cdc15 (Figure 2b), suggesting that Cdc14 is a more specific
Cdc15 phosphatase under these conditions. To confirm that
Cdc14 can promote Cdc15 dephosphorylation in vivo, we
found that overexpression of CDC14 in mitotically arrested
cells abolished Cdc15 phosphorylation (Figure 2c). The
effects of CDC14 overexpression were not simply an indirect
consequence of mitotic exit, because similar results were
obtained in a cdc23-1 mutant at the restrictive temperature
(Figure 2c). We therefore propose that Cdc14 is responsible
for Cdc15 dephosphorylation at the end of anaphase. 
Our observation that Cdc15 is dephosphorylated at the end
of mitosis by Cdc14 might suggest that phosphorylation
negatively regulates Cdc15 activity. However, immuno-pre-
cipitates of phosphorylated wild-type Cdc15 and nonphos-
phorylated Cdc15-7A contained the same amounts of kinase
activity (Figure 2c and see Supplementary material). In
addition, dephosphorylation of Cdc15 in vivo by overexpres-
sion of Cdc14 resulted in little change in Cdc15-associated
kinase activity (Figure 2c). Finally, Cdc15-associated kinase
activity did not fluctuate in cells released from a metaphase
arrest (Figure 1d). It therefore seems likely that phosphory-
lation does not affect the intrinsic catalytic activity of Cdc15. 
To assess the role of phosphorylation in Cdc15 function
in vivo, we analyzed the effect of Cdc15-7A overexpression
on Cdk inactivation during mitosis. In cells arrested in
mitosis with nocodazole, expression of Cdc15-7A, but not
that of wild-type Cdc15, caused a decrease in the levels of
the mitotic cyclins, Clb2 and Clb3, an increase in the level
of Sic1, and a decrease in Clb2-associated Cdc28 kinase
activity (Figure 3a). Although cells overexpressing
Cdc15-7A rebudded (data not shown), they did not com-
plete all mitotic events — Pds1 levels remained high and
sister chromatids did not separate (Figure 3a and data not
shown). The ability of Cdc15-7A to induce Cdk inactiva-
tion was dependent on the functions of both Hct1 and
Sic1 (see Supplementary material). 
To further examine the effect of Cdc15 phosphorylation
on cell cycle progression, we constructed a yeast strain in
which CDC15-7A was the only copy of CDC15 in the cell.
These cells were viable, morphologically identical to wild-
type cells (data not shown), and progressed through the
cell cycle with wild-type kinetics (see Supplementary
material). However, the CDC15-7A strain was unique in its
genetic requirements for mitotic exit. Removal of the
Cdc15 phosphorylation sites allowed proliferation of
cdc5-1, dbf2-2, or tem1-3 mutants at 37°C (Figure 3b). In
particular, the growth of tem1-3 strains expressing
CDC15-7A, in the presence or absence of wild-type
CDC15, was nearly as robust as the growth of wild-type
cells (Figure 3b and data not shown). CDC15-7A did not
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Figure 1
Cdc15 is phosphorylated in vivo at
Cdk-consensus sites and dephosphorylated
transiently at the end of anaphase.
(a) Wild-type strains containing
GAL–CDC15HA or GAL–CDC15HA-7A
were grown in 4% galactose for 2.5 h.
Cdc15HA proteins were immunoprecipitated
from cell lysates and treated with phosphatase
buffer (lanes 2,5), 100 U l -phosphatase (lanes
3,6), or both l -phosphatase and phosphatase
inhibitors (lanes 4,7). Lane 1 is an
immunoprecipitate from cells lacking
epitope-tagged Cdc15. Immunoprecipitates
were immunoblotted with anti-HA antibody
16B12. (b) Wild-type strains containing
GAL–CDC15HA (WT) or GAL–CDC15HA-
7A (7A) were arrested with a -factor (a f),
hydroxyurea (HU), or nocodazole (Noc), or left
as asynchronous cultures (7A, asyn) for 3 h.
Galactose was then added to 4% for an
additional 1.5 h. Lysates were analyzed by
western blotting with 16B12. (c) The indicated
temperature-sensitive mutants containing
CDC15HA3 expressed from the endogenous
promoter were grown at 23°C or were
arrested in anaphase by shifting to 37°C for
4 h. Cdc15HA3 was detected by western
blotting with 16B12. Changes in Cdc15HA3
levels are due to differences in the amount of
total protein loaded (data not shown).
(d) A cdc20D GAL–CDC20 strain containing
CDC15HA3 expressed from the endogenous
promoter was transferred to raffinose-
containing media to arrest cells in metaphase.
Cells were released from the arrest into G1 by
the addition of 2% galactose and 5 m g/ml
a -factor. At the indicated times, samples were
withdrawn to analyze Clb2, Sic1 and Cdc28
protein levels, Cdc15 phosphorylation,
Cdc15-associated kinase activity towards
myelin basic protein (MBP), and
Clb2-associated Cdc28 kinase activity
towards Histone H1 (HH1). The percentage of
cells at each time point exhibiting the indicated
budding and spindle morphologies is shown in
the bottom panel. The dephosphorylation of
Cdc15 in late mitosis was observed
reproducibly in four separate experiments. 
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suppress the growth defect of cells from which TEM1 was
deleted (data not shown). In addition, mitotic exit in
CDC15-7A strains still required the function of Cdc14. 
Components of the mitotic exit network, including Cdc15,
are thought to be upstream activators of Cdc14 release
from the nucleolus [5,6]. Our present results, however,
suggest that Cdc15 is a downstream substrate of Cdc14.
One interpretation of these results is that the ability of
Cdc14 to activate Cdc15 leads to a positive-feedback loop
that enhances Cdc14 activation in late mitosis. To test this
possibility, we analyzed the release of Cdc14 from the
nucleolus in cells arrested in late mitosis by a cdc14-1
mutation. These cells arrest with highly phosphorylated
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Figure 2
Cdc14 promotes Cdc15 dephosphorylation
in vitro and in vivo. (a) Wild-type strains
containing GAL–CDC15HA or
GAL–CDC15HA-7A were grown in 4%
galactose for 2.5 h. Cdc15HA proteins were
immunoprecipitated from cell lysates and
incubated with buffer alone (–), 1 m g GST, 1 m g
GST–Cdc14, 1 m g GST–Cdc14-C/R (an
inactive double mutant), or 200 U
l -phosphatase. Immunoprecipitates were then
immunoblotted with 16B12. (b) Crude cell
lysates (1 mg) were incubated for 30 min at
30°C with buffer alone (–), 5 m g GST, 5 m g
GST–Cdc14, 5 m g GST–Cdc14-C/R or 1,600
U l -phosphatase. Cdc15HA was
immunoprecipitated from the reactions and
detected by immunoblotting with 16B12.
(c) Strains containing wild-type (WT) CDC23
(cdc15D CDC15HA3 and cdc15D
CDC15HA3-7A), as well as cdc23-1
CDC15HA3, cdc23-1 CDC15HA3-7A, and
cdc23-1 strains, each containing
GAL–CDC14, were arrested in mitosis by
treatment with 15 m g/ml nocodazole for 2 h.
Cultures were shifted to 35°C for 30 min to
inactivate cdc23, followed by addition of 2%
dextrose (–) or 4% galactose (+) for 2 h at
35°C. Cdc15HA3, Clb2 and Cdc14 were
detected by immunoblotting. Cdc15HA or
Cdc15HA-7A were immunoprecipitated from
2 mg of lysate and tested for their ability to
autophosphorylate (third panel) or phosphorylate
myelin basic protein (MBP, bottom panel).
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Figure 3
Cdc15-7A promotes Cdk inactivation and mitotic exit in vivo.
(a) A pds1 D ::PDS1myc18 strain containing vector,
GAL–CDC15HA, or GAL–CDC15HA-7A was arrested in mitosis
by treatment with 15 m g/ml nocodazole, followed by addition of 4%
galactose for 3 h. Levels of Cdc15, Pds1, Clb2, Clb3, Sic1 and
Cdc28 were measured by immunoblotting. Cyclin–ubiquitin
ligase activity of the anaphase-promoting complex (APC) was
measured in anti-Cdc26 immunoprecipitates, and Cdc28-associated
kinase activity toward HH1 was measured in anti-Clb2
immunoprecipitates. (b) Log-phase cells with the indicated
genotypes (generated through genetic crosses; see Supplementary
material for details) were serially diluted threefold and spotted
onto YPD plates. Plates were incubated for 2 days at 23°C or
1.5 days at 37°C. 
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Cdc15 (Figure 1c); thus, if Cdc15 dephosphorylation is
required for Cdc14 activation, then cdc14-1 cells should
arrest with Cdc14 still sequestered in the nucleolus.
Wild-type and cdc14-1 mutant cells were released from a G1
arrest and shifted to a non-permissive temperature to arrest
mutant cells in anaphase (Figure 4 and see Supplementary
material). Wild-type Cdc14 and the mutant Cdc14-1 protein
were initially sequestered in the nucleolus. As wild-type
cells progressed through anaphase and elongated the mitotic
spindle, Cdc14 was redistributed into the nucleus and cyto-
plasm, and then returned to the nucleolus upon entry into
the following G1 (Figure 4). Although cdc14-1 mutant cells
entered anaphase slightly later than wild-type cells, the
mutant Cdc14-1 protein also dispersed throughout the cell
in late mitosis, and remained dispersed at the cdc14-1-arrest
point (Figure 4). Thus, Cdc14 function is not required for
its release from the nucleolus, suggesting that Cdc15
dephosphorylation and positive feedback are not essential
for Cdc14 activation under these conditions. 
In conclusion, our results argue that the ability of Cdc15 to
promote the exit from mitosis is negatively regulated by
phosphorylation. First, we observed that Cdc15 is tran-
siently dephosphorylated in late mitosis. Second, ectopic
expression of a non-phosphorylatable form of Cdc15, but
not wild-type Cdc15, caused partial Cdk inactivation and
rebudding in metaphase-arrested cells. Finally, and perhaps
most importantly, removal of Cdc15 phosphorylation sites
allowed proliferation of mutants with otherwise lethal
defects in mitotic exit. Dephosphorylation of Cdc15 may
promote some function of the protein that is distinct from
its role in Cdc14 activation. Studies of several cdc15 mutant
alleles suggest that Cdc15 might play multiple roles during
mitosis [7,8]. In particular, characterization of the cdc15-lyt1
mutant phenotype suggests that Cdc15 function is critical
for formation of an active division septum, which is required
for cytokinesis. On the basis of this and other work in
budding yeast [7,9], as well as studies of the Cdc15 homolog
Cdc7 in fission yeast [10], it seems likely that Cdc15 might
be involved in the direct control of cytokinesis. We specu-
late that Cdc15 dephosphorylation promotes this or some
related aspect of Cdc15 function, not by changing its kinase
activity but perhaps by changing its subcellular localization. 
Supplementary material
Additional methodological details, as well as figures showing studies of
Cdc15 phosphorylation in various kinase mutants, the effect of Cdc15-
7A in hct1 and sic1 mutants, and Cdc14 immunofluorescence data,
are available at http://current-biology.com/supmat/supmatin.htm. 
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Figure 4
Dephosphorylation of Cdc15 is not required for Cdc14 release from the
nucleolus. Cells in which the endogenous wild-type CDC14 (Mata bar1
CDC14::CDC14–GFP) or mutant cdc14-1 (Mata bar1 cdc14-1::cdc14-
1–GFP) gene is tagged at the carboxyl terminus with GFP were
synchronized in G1 by treatment with 1 m g/ml a -factor for 3 h at 23°C,
then released into fresh media at 23°C. Cultures were shifted to 34°C to
inactivate cdc14-1 30 min after release, and 50 min after release, 1 m g/ml
a -factor was added to re-arrest wild-type cells in the subsequent G1.
Samples withdrawn every 15 min were fixed and analyzed by indirect
immunofluorescence microscopy to determine the morphology of the
mitotic spindle and the localization of Cdc14–GFP and Cdc14-1–GFP
at each time point. The percentage of cells containing anaphase spindles
(open symbols) and delocalized Cdc14 (closed symbols) at each time
point was quantitated. More than 200 cells were counted at each time
point. See Supplementary material for immunofluorescence images and
analysis of Clb2 and Cdc14 protein levels in this experiment.
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